This just completed on 15th Feb, 2023 by Henslow with another tech company, $40 mill mkt cap (CCA)
"Henslow is pleased to have acted as Corporate Advisor to Change Financial (ASX:CCA) on a A$6.9m sole placement to US-based strategic fintech investor Michael Giles. Following completion of the placement, Mr Giles will hold a 19.99% shareholding in Change.The placement will result in the issue of approximately 114.3 million new shares and was conducted at an offer price of $0.06 per new share representing a 17.8% premium to the 10-day VWAP and 17.6% premium to the last close price on 15 February 2023.
Change Financial is an ASX-listed fintech providing global payment processing and card (both virtual and physical) issuing services and technologies to banks, financial institutions (credit unions), and fintechs. Over the past 18 months the Change team has worked hard to establish core building blocks – partnerships, compliance, technology and talent – all of which are now in place to deliver on their longer-term growth plan."
- Forums
- ASX - By Stock
- AMS
- Ann: AGM Presentation
Ann: AGM Presentation, page-37
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.37M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.5¢ | $49.93K | 1.997M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2691 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 126993 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2691 | 0.025 |
6 | 671174 | 0.024 |
5 | 690969 | 0.021 |
5 | 567830 | 0.020 |
1 | 100000 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 126993 | 4 |
0.027 | 50000 | 1 |
0.028 | 107000 | 2 |
0.029 | 100000 | 1 |
0.030 | 1211352 | 6 |
Last trade - 12.20pm 12/11/2024 (20 minute delay) ? |
Featured News
AMS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online